Skip to content
10-Q

Quarterly Report

Bioventus Inc. BVS

0001665988-25-000026

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 27, 2025 68.84M sh
Shares Diluted Q3 2025 · Sep 27, 2025 68.79M sh
Shares Diluted Q3 2025 · Sep 28, 2024 65.26M sh
Shares Diluted Q3 2025 · Sep 28, 2024 64.23M sh
Capex Q3 2025 · Sep 27, 2025 $1.98M
Capex Q3 2025 · Sep 28, 2024 $432K
Operating Cash Flow Q3 2025 · Sep 27, 2025 $36.71M
Operating Cash Flow Q3 2025 · Sep 28, 2024 $19.47M
Long Term Debt Q3 2025 · Sep 27, 2025 $311.33M
Long Term Debt Q3 2025 · Dec 31, 2024 $308.29M
Short Term Debt Q3 2025 · Sep 27, 2025 $11.25M
Short Term Debt Q3 2025 · Dec 31, 2024 $27.34M
Cash And Equivalents Q3 2025 · Sep 27, 2025 $42.16M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $41.58M
Stockholders Equity Q3 2025 · Sep 27, 2025 $166.1M
Stockholders Equity Q3 2025 · Dec 31, 2024 $147.94M
Current Liabilities Q3 2025 · Sep 27, 2025 $161.75M
Current Liabilities Q3 2025 · Dec 31, 2024 $210.4M
Total Liabilities Q3 2025 · Sep 27, 2025 $494.34M
Total Liabilities Q3 2025 · Dec 31, 2024 $542.35M
Current Assets Q3 2025 · Sep 27, 2025 $280.9M
Current Assets Q3 2025 · Dec 31, 2024 $275.61M
Total Assets Q3 2025 · Sep 27, 2025 $701.59M
Total Assets Q3 2025 · Dec 31, 2024 $727.96M
Eps Diluted Q3 2025 · Sep 27, 2025 $0.05
Eps Diluted Q3 2025 · Sep 27, 2025 $0.12
Eps Diluted restated Q3 2025 · Sep 28, 2024 −$0.08
Eps Diluted restated Q3 2025 · Sep 28, 2024 −$0.56
Eps Basic Q3 2025 · Sep 27, 2025 $0.05
Eps Basic Q3 2025 · Sep 27, 2025 $0.12
Eps Basic restated Q3 2025 · Sep 28, 2024 −$0.08
Eps Basic restated Q3 2025 · Sep 28, 2024 −$0.56
Sga Expense Q3 2025 · Sep 27, 2025 $78.66M
Sga Expense Q3 2025 · Sep 27, 2025 $231.27M
Sga Expense restated Q3 2025 · Sep 28, 2024 $81.48M
Sga Expense restated Q3 2025 · Sep 28, 2024 $256.93M
Rd Expense Q3 2025 · Sep 27, 2025 $2.92M
Rd Expense Q3 2025 · Sep 27, 2025 $9.11M
Rd Expense restated Q3 2025 · Sep 28, 2024 $3.84M
Rd Expense restated Q3 2025 · Sep 28, 2024 $10.68M
Net Income Q3 2025 · Sep 27, 2025 $3.16M
Net Income Q3 2025 · Sep 27, 2025 $7.98M
Net Income restated Q3 2025 · Sep 28, 2024 −$5.17M
Net Income restated Q3 2025 · Sep 28, 2024 −$35.74M
Operating Income Q3 2025 · Sep 27, 2025 $11.25M
Operating Income Q3 2025 · Sep 27, 2025 $34.49M
Operating Income restated Q3 2025 · Sep 28, 2024 $3.65M
Operating Income restated Q3 2025 · Sep 28, 2024 −$22.9M
Gross Profit Q3 2025 · Sep 27, 2025 $94.23M
Gross Profit Q3 2025 · Sep 27, 2025 $279.38M
Gross Profit Q3 2025 · Sep 28, 2024 $93.55M
Gross Profit Q3 2025 · Sep 28, 2024 $285.57M
Cost Of Revenue Q3 2025 · Sep 27, 2025 $44.42M
Cost Of Revenue Q3 2025 · Sep 27, 2025 $130.81M
Cost Of Revenue Q3 2025 · Sep 28, 2024 $45.41M
Cost Of Revenue Q3 2025 · Sep 28, 2024 $134.07M
Revenue Q3 2025 · Sep 27, 2025 $138.65M
Revenue Q3 2025 · Sep 27, 2025 $410.19M
Revenue Q3 2025 · Sep 28, 2024 $138.96M
Revenue Q3 2025 · Sep 28, 2024 $419.64M